Here’s Why Davis Funds Became Optimistic in Viatris (VTRS)
Davis Funds, an investment management firm, published its “Davis Global Fund” fourth quarter 2021 investor letter – a copy of which can be downloaded here.
Viatris Inc (VTRS)
Get Email AlertsSector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Laurion Capital Management Benjamin A. Smith | 29,392,002 | $319,785 | -15% | 3.91% |
| 2. | Camber Capital Management Stephen Dubois | 23,000,000 | $250,240 | +44% | 9.05% |
| 3. | Deerfield Management James E. Flynn | 20,673,700 | $224,930 | -1% | 5.02% |
| 4. | Citadel Investment Group Ken Griffin | 9,836,232 | $107,018 | +126% | 0.02% |
| 5. | Marshall Wace LLP Paul Marshall And Ian Wace | 8,090,176 | $88,018 | +234% | 0.16% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $9.90 | 2,700 | Director | 22,031 | 2022-03-15 | Filing | |
| $9.87 | 50,352 | Officer, Director | 136,796 | 2022-03-15 | Filing | |
| $15.45 | 500 | Director | 5,000 | 2021-05-21 | Filing | |
| $15.79 | 1,500 | Director | 4,500 | 2021-05-19 | Filing | |
| $13.84 | 3,000 | Director | 3,000 | 2021-03-03 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $10.07 | 250,000 | Officer, Director | 0 | 2022-03-11 | Filing | |
| $10.28 | 250,000 | Officer, Director | 250,000 | 2022-03-09 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 4,616,915 | $50,232,036 | 0.02% | |
| 2. | 287,855 | $3,131,862 | 0.46% | |
| 3. | 279,419 | $3,040,079 | 0.01% | |
| 4. | 184,092 | $2,002,921 | 0.02% | |
| 5. | 138,356,610 | $1,505,319 | 0.03% |
News See All
Is Viatris (VTRS) A Smart Long-Term Pick?
Davis Funds, an investment management firm, published its “Davis Opportunity Fund” fourth-quarter 2021 investor letter – a copy of which can be downloaded here.
Robert Pohly’s Samlyn Capital Portfolio: 5 Dividend Stock Picks
In this article, we discuss the 5 dividend stocks in Robert Pohly's portfolio.
Why These 10 Stocks Are Moving on Monday
All three major indexes are in the red today, with the S&P 500 down 1.10%, the Dow Jones down 1.2%, and the NASDAQ 100 down 0.59%.
10 Cheap Pharmaceutical Stocks For 2022
The pharma industry is in the midst of a fundamental transformation as disruptive technologies like artificial intelligence, machine learning, and natural language processing become dominant trends in...
Were Hedge Funds Right About Viatris Inc. (VTRS)?
We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors...
10 Healthcare Dividend Stocks with Over 3% Yield
In this article, we discuss the 10 healthcare dividend stocks with over 3% yield.
Is Viatris Inc. (VTRS) A Good Stock To Buy?
Last year we predicted the arrival of the first US recession since 2009 and we told in advance that the market will decline by at least 20% in (Recession is Imminent: We Need A Travel Ban NOW).
Is Viatris (VTRS) A Wise Investment Choice?
Davis Funds, an investment management firm, published its “Davis Opportunity Fund” third quarter 2021 investor letter – a copy of which can be downloaded here.
Top 5 Stock Picks of Benjamin Smith’s Laurion Capital Management
In this article, we discuss the top 5 stock picks of Benjamin Smith's Laurion Capital Management.
Billionaire Hedge Funds
